TMO
Thermo Fisher Scientific Inc.
Price performance
Sep 18, 2026About
Company activity
26 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 07/23 | TMO | 8-K | Thermo Fisher Scientific Reports Strong Q2 2026 Financial Results | — | — | — |
| 05/26 | TMO | 8-K | Thermo Fisher Scientific Elects New Board Members and Receives Advisory Vote Results | — | — | — |
| 04/23 | TMO | 8-K | Thermo Fisher Scientific Reports Strong Q1 2026 Results with Revenue and EPS Growth | — | — | — |
| 03/24 | TMO | 8-K | Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. | — | — | — |
| 02/12 | TMO | 8-K | Thermo Fisher Scientific Issues $3.76 Billion in Senior Notes | — | — | — |
| 01/29 | TMO | 8-K | Thermo Fisher Scientific Reports Q4 and Full-Year 2025 Financial Results | — | — | — |
| 01/12 | TMO | 8-K | Thermo Fisher Scientific Announces Key Leadership Changes | — | — | — |
| 12/01/25 | TMO | 8-K | Thermo Fisher Scientific Announces Issuance of Senior Notes | — | — | — |
| 10/29/25 | TMO | 8-K | Thermo Fisher Scientific to Acquire Clario Holdings, Inc. for $8.875 Billion | — | — | — |
| 10/22/25 | TMO | 8-K | Thermo Fisher Scientific Reports 5% Revenue Growth and 10% Adjusted EPS Growth in Q3 2025 | — | — | — |
| 10/07/25 | TMO | 8-K | Thermo Fisher Scientific Inc. Issues $2.5 Billion in Senior Notes | — | — | — |
| 09/02/25 | TMO | 8-K | Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business | — | — | — |
| 07/23/25 | TMO | 8-K | Thermo Fisher Scientific Announces CFO Retirement and Successor | — | — | — |
| 07/23/25 | TMO | 8-K | Thermo Fisher Scientific Announces Second Quarter 2025 Financial Results | — | — | — |
| 05/28/25 | TMO | 8-K | Thermo Fisher Scientific Inc. Announces Board Election Results at Annual Meeting | — | — | — |
| 05/22/25 | TMO | 8-K | Thermo Fisher Scientific Approves Long-Term Incentive Award for CEO | — | — | — |
| 04/23/25 | TMO | 8-K | Thermo Fisher Scientific Announces First Quarter 2025 Results | — | — | — |
| 02/25/25 | TMO | 8-K | Thermo Fisher Scientific Announces Acquisition of Solventum's Purification and Filtration Business | — | — | — |
| 02/19/25 | TMO | 8-K | Thermo Fisher Scientific Appoints New Director Karen S. Lynch | — | — | — |
| 01/30/25 | TMO | 8-K | Thermo Fisher Scientific Reports Strong Q4 and FY 2024 Financial Results | — | — | — |
| 10/23/24 | TMO | 8-K | Thermo Fisher Scientific Reports Q3 2024 Financial Results | — | — | — |
| 07/24/24 | TMO | 8-K | Thermo Fisher Reports Q2 2024 Results and Raises Guidance | — | — | — |
| 07/10/24 | TMO | 8-K | Thermo Fisher Completes Tender Offer for Olink Holding AB | — | — | — |
| 05/24/24 | TMO | 8-K | Thermo Fisher Scientific Shareholders Approve Key Proposals at Annual Meeting | — | — | — |
| 04/24/24 | TMO | 8-K | Thermo Fisher Scientific Reports Q1 2024 Financial Results and Raises Guidance | — | — | — |
| 01/31/24 | TMO | 8-K | Thermo Fisher Scientific Reports Fourth Quarter 2023 Financial Results | — | — | — |
TMO filing record
Thermo Fisher Scientific Inc. (TMO): 26 8-K filings summarized, the most recent on Jul 23, 2026.
What the 8-K filings said
- Jul 23, 2026 · medium impact
Thermo Fisher Scientific Inc. reported its financial results for the second quarter of 2026, showing a 10% increase in revenue to $11.99 billion. The company achieved 9% growth in GAAP diluted earnings per share (EPS) to $4.68 and 13% growth in adjusted EPS to $6.03. Organic revenue growth was 5%. The company advanced…
Thermo Fisher Scientific Reports Strong Q2 2026 Financial Results - May 26, 2026 · medium impact
At the Annual Meeting held on May 20, 2026, Thermo Fisher Scientific's shareholders elected ten new members to the Company's Board of Directors. The non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved. The appointment of PricewaterhouseCoopers LLP as the…
Thermo Fisher Scientific Elects New Board Members and Receives Advisory Vote Results - Apr 23, 2026 · high impact
Thermo Fisher Scientific Inc. reported its financial results for the first quarter of 2026, showing a 6% increase in revenue to $11.01 billion and a 11% increase in GAAP diluted EPS to $4.43. The company also announced strategic collaborations with NVIDIA and SHL Medical, the acquisition of Clario, and a $3.0 billion…
Thermo Fisher Scientific Reports Strong Q1 2026 Results with Revenue and EPS Growth - Mar 24, 2026 · high impact
Thermo Fisher Scientific Inc. has completed its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, with potential additional payments based on performance. The acquisition is expected to contribute $0.45 of adjusted earnings per share in…
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. - Feb 12, 2026 · high impact
On February 12, 2026, Thermo Fisher Scientific Inc. issued $3.76 billion in senior notes through a public offering. The notes consist of $1 billion of 4.215% Senior Notes due 2031, $750 million of 4.550% Senior Notes due 2033, $1.3 billion of 4.902% Senior Notes due 2036, and $750 million of 5.546% Senior Notes due…
Thermo Fisher Scientific Issues $3.76 Billion in Senior Notes
SEC filings in the last five years
- 52 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 8-K/A